Babar Bashir

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Cancer biology & therapy

Journal of gastrointestinal oncology

Immunotherapy

JCO oncology practice

Thomas Jefferson University

Thomas Jefferson University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Jul 01 2019

United States

Assistant Professor :: Medical Oncology

Thomas Jefferson University Hospitals Jul 01 2017 - Jun 30 2019

United States

Fellow :: Medical Oncology

Thomas Jefferson University Jul 01 2016 - Jun 30 2018

United States

Fellow :: Pharmacology & Experimental Therapeutics

Education History

Thomas Jefferson University - May 23 2018

United States

MSC :: Pharmacology

Publications

Daniel S Lefler, Steven A Manobianco, Babar Bashir
Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer biology & therapy 25 (1) (2024)
Matthew D Bloom, Babar Bashir
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers. Journal of gastrointestinal oncology 15 (3) (2024)
Matthew D Bloom, Babar Bashir
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers. Journal of gastrointestinal oncology 15 (3) (2024)
Daniel S Lefler, Steven A Manobianco, Babar Bashir
Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer biology & therapy 25 (1) (2024)
Daniel S Lefler, Steven A Manobianco, Babar Bashir
Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer biology & therapy 25 (1) (2024)
Daniel S Lefler, Steven A Manobianco, Babar Bashir
Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer biology & therapy 25 (1) (2024)
Daniel S Lefler, Steven A Manobianco, Babar Bashir
Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer biology & therapy 25 (1) (2024)
Babar Bashir, Judy S Wang, Gerald S Falchook, Elisa Fontana, Hendrick-Tobias Arkenau, Louise Carter, Rachel Galot, Bristi Basu, Alastair P Greystoke, Vivek Subbiah, Debra L Richardson, Hanna Orr, Gavin Bennett, Rajiv Sharma, Hongmei Xu, Paola Paganoni, Cong Xu, Carly Campbell, Meredith A McKean
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Grant W Jirka, Daniel S Lefler, Jessica Russo, Babar Bashir
Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer biology & therapy 24 (1) (2023)
Sameh Gomaa, James Posey, Babar Bashir, Atrayee Basu Mallick, Eleanor Vanderklok, Max Schnoll, Tingting Zhan, Kuang-Yi Wen
Feasibility of a Text Messaging-Integrated and Chatbot-Interfaced Self-Management Program for Symptom Control in Patients With Gastrointestinal Cancer Undergoing Chemotherapy: Pilot Mixed Methods Study. JMIR formative research 7 (2023)
Grant W Jirka, Daniel S Lefler, Jessica Russo, Babar Bashir
Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer biology & therapy 24 (1) (2023)
Grant W Jirka, Daniel S Lefler, Jessica Russo, Babar Bashir
Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer biology & therapy 24 (1) (2023)
Grant W Jirka, Daniel S Lefler, Jessica Russo, Babar Bashir
Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer biology & therapy 24 (1) (2023)
Holly Mansell, Ahmed Shoker, Jane Alcorn, Mark E Fenton, Julian S Tam, William Semchuk, Babar Bashir, Walter K Kraft, Shenzhen Yao, James D Douketis
Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients. Clinical and translational science 15 (7) (2022)
Babar Bashir, Adam C Mueller
Pancreatic Adenocarcinoma: An Evolving Yet Unimpressive Treatment Landscape. JCO oncology practice (2022)
Daniel S Lefler, Adam E Snook, Babar Bashir
Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1. Immunotherapy 14 (11) (2022)
Daniel S Lefler, Marni Brisson Tierno, Babar Bashir
Partial treatment response to capmatinib in MET -amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature. Cancer biology & therapy 23 (1) (2022)
Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A Mesa, Sanjay Mishra, Daniel P Mundt, Dimpy P Shah, R Alejandro Sica, Keith E Stockerl-Goldstein, Catherine S M Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa K Accordino, Sarit E Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie A Berg, Mehmet Asim Bilen, Cecilia A Castellano, Jacob C Cogan, Devendra Kc, Christopher R Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A Johnson, Monika Joshi, Anup Kasi Loknath Kumar, Elizabeth J Klein, Vadim S Koshkin, Nicole M Kuderer, Daniel H Kwon, Chris Labaki, Tahir Latif, Eric K C Lau, Xuanyi Li, Gary H Lyman, Rana R McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K Nonato, Adam J Olszewski, Hyma V Polimera, Andrew Jay Portuguese, Matthew M Puc, Pedram Razavi, Rachel Rosovski, Andrew L Schmidt, Sumit A Shah, Aditi Shastri, Christopher T Su, Pallawi Torka, Trisha Michel Wise-Draper, Leyre Zubiri, Jeremy L Warner, Michael A Thompson, null null
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. Blood cancer discovery 3 (3) (2022)
Babar Bashir, John C Flickinger, Adam E Snook
Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers. Immunotherapy 13 (7) (2021)
Erik S Blomain, Jeffrey A Rappaport, Amanda M Pattison, Babar Bashir, Ellen Caparosa, Jonathan Stem, Adam E Snook, Scott A Waldman
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis. Cancer biology & therapy 21 (5) (2020)
Edwin Lam, Babar Bashir, Mark Chaballa, Walter K Kraft
Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy. Expert review of clinical pharmacology 12 (8) (2019)
Babar Bashir, Adam E Snook
Immunotherapy regimens for metastatic colorectal carcinomas. Human vaccines & immunotherapeutics 14 (2) (2017)

Babar Bashir.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Babar Bashir